InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Hively Brad, Chief Executive Officer. Insider active across 2 companies, notably Oncology Institute, Inc.. Cumulatively, 23 reports have been logged. Split: 2 buys · 4 sells. Total volume traded: €1.8m. History available since 12 January 2021. The latest transaction was filed on 21 August 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Hively Brad
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
298,853 shares@ US$6.51260.29% mcap100.0% of flowCommon StockSEC:0001079973-26-001175:0
27,108 shares0Common StockSEC:0001079973-26-000983:0
13,333 shares@ US$3.77195.1% of flowCommon StockSEC:0001079973-25-001861:0
41,667 shares0Common StockSEC:0001553350-25-000143:0
20,221 shares@ US$4.068.8% of flowCommon stockSEC:0000935836-25-000552:0
684,528 shares@ US$0.8570.1% of flowCommon StockSEC:0000935836-25-000416:0
45,280 shares@ US$1.041720.1% of flowCommon StockSEC:0000935836-25-000296:0
Canonical exit: 24 Jun 2025 (T+90)
9,056 shares@ US$1.04174.0% of flowCommon StockSEC:0001079973-25-000521:0
Canonical exit: 24 Jun 2025 (T+90)
353,450 shares0Common stockSEC:0001799191-24-000063:0
44,000 shares0Common stockSEC:0001799191-24-000050:0
18,121 shares@ US$0.45783.6% of flowCommon StockSEC:0001799191-24-000015:0
19,526 shares@ US$0.57534.8% of flowCommon StockSEC:0001799191-24-000013:0
42,652 shares0Common stockSEC:0001628280-23-042829:0
25,867 shares@ US$2.19323.8% of flowCommon stockSEC:0001628280-23-039913:0
25,000 shares@ US$0.859.0% of flowCommon stockSEC:0001628280-23-039815:0
47,000 shares@ US$0.8517.2% of flowCommon stockSEC:0001628280-23-039192:0
168,512 shares0Common stockSEC:0001628280-23-008825:0
9,718 shares@ US$2.02788.8% of flowCommon StockSEC:0001799191-22-000050:0
103,469 shares0Common StockSEC:0001799191-22-000032:0
9,718 shares@ US$2.02788.8% of flowCommon StockSEC:0001799191-22-000012:0
108,469 shares0Common stockSEC:0001628280-22-007101:0
141,380 shares0Common StockSEC:0001104659-21-141460:0
141,380 shares0Common StockSEC:0001104659-21-140219:0
23 of 23 declarations
About Hively Brad
Hively Brad is Directeur Général and a director of Oncology Institute, Inc. (XNAS). He has 21 filings in total, and across the sampled recent filings between 2021-11-16 and 2025-12-16, the buy and sell amounts are 52470 EUR and 221478 EUR, respectively, with the modal transaction nature listed as Attribution.
